Interleukin-17 inhibition: a route to psoriasis clearance?

Sophie Cypowyj, Capucine Picard, László Maródi, Jean‐Laurent Casanova, Anne Puel, None, Immunity to infection in IL-17-deficient mice and humans. European Journal of Immunology. ,vol. 42, pp. 2246- 2254 ,(2012) , 10.1002/EJI.201242605

Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher EM Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson, Enrique Rivas, Tsen-Fang Tsai, Norman Wasel, Stephen Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, Charis Papavassilis, None, Secukinumab in plaque psoriasis--results of two phase 3 trials. The New England Journal of Medicine. ,vol. 371, pp. 326- 338 ,(2014) , 10.1056/NEJMOA1314258

L. Puig, PASI90 response: the new standard in therapeutic efficacy for psoriasis Journal of The European Academy of Dermatology and Venereology. ,vol. 29, pp. 645- 648 ,(2015) , 10.1111/JDV.12817

William O'Connor Jr, Masahito Kamanaka, Carmen J Booth, Terrence Town, Susumu Nakae, Yoichiro Iwakura, Jay K Kolls, Richard A Flavell, A protective function for interleukin 17A in T cell–mediated intestinal inflammation Nature Immunology. ,vol. 10, pp. 603- 609 ,(2009) , 10.1038/NI.1736

Sarah L Gaffen, Recent advances in the IL-17 cytokine family Current Opinion in Immunology. ,vol. 23, pp. 613- 619 ,(2011) , 10.1016/J.COI.2011.07.006

Tabassome Simon, Soraya Taleb, Nicolas Danchin, Ludivine Laurans, Benoit Rousseau, Simon Cattan, Jean-Michel Montely, Olivier Dubourg, Alain Tedgui, Salma Kotti, Ziad Mallat, Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. European Heart Journal. ,vol. 34, pp. 570- 577 ,(2013) , 10.1093/EURHEARTJ/EHS263

Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter DR Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, Claudia Berger, Marco Londei, Arthur P Bertolino, Gervais Tougas, Simon PL Travis, Secukinumab in Crohn's Disease Study Group, None, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Gut. ,vol. 61, pp. 1693- 1700 ,(2012) , 10.1136/GUTJNL-2011-301668

Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest, Susan Ball, Daniel K Braun, Olawale O Osuntokun, Michael P Heffernan, Brian J Nickoloff, Kim Papp, Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials The Lancet. ,vol. 386, pp. 541- 551 ,(2015) , 10.1016/S0140-6736(15)60125-8